Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
17.26
+0.20 (1.17%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Trevi Therapeutics Employees
Trevi Therapeutics had 34 employees as of December 31, 2025. The number of employees increased by 8 or 30.77% compared to the previous year.
Employees
34
Change (1Y)
8
Growth (1Y)
30.77%
Revenue / Employee
n/a
Profits / Employee
-$1,503,147
Market Cap
2.46B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | 8 | 30.77% |
| Dec 31, 2024 | 26 | 1 | 4.00% |
| Dec 31, 2023 | 25 | 0 | - |
| Dec 31, 2022 | 25 | 1 | 4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Vera Therapeutics | 361 |
| Ocular Therapeutix | 325 |
| Nuvation Bio | 305 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| Precigen | 160 |
TRVI News
- 4 days ago - Trevi Therapeutics to Participate in Upcoming September Conferences - GlobeNewsWire
- 12 days ago - Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026 - GlobeNewsWire
- 22 days ago - Trevi Therapeutics price target raised to $28 from $24 at Jones - TheFly
- 4 weeks ago - Trevi Therapeutics price target raised to $23 from $20 at Morgan Stanley - TheFly
- 4 weeks ago - Trevi Therapeutics price target raised to $40 from $27 at Raymond James - TheFly
- 4 weeks ago - Trevi Therapeutics price target raised to $30 from $25 at Cantor Fitzgerald - TheFly
- 4 weeks ago - Trevi Therapeutics price target raised to $25 from $24 at Oppenheimer - TheFly
- 4 weeks ago - Trevi Therapeutics reports Q2 EPS (11c), consensus (11c) - TheFly